Jacob Kerkin
Jacob Kerkin is an investment manager at Omni Bridgeway in New Zealand, involved in financing a class action lawsuit aimed at challenging the efficacy of phenylephrine in cold and flu medications sold to consumers.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| New Zealand | 2 | 4.00 | 0.09% | +0% | 4,822,233 | 4,342 | $210,000 | 189$ |
| Totals | 2 | 4,822,233 | 4,342 | $210,000 | 189$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Jacob Kerkin stated that New Zealanders have been sold ineffective cold and flu products for around 20 years.
4
New Zealand:
Jacob Kerkin stated that New Zealanders have been sold ineffective cold and flu products for around 20 years.
4